Science Explorer Back to mapMap
Discussion
Company · Ulaanbaatar · Mongolia

Immunitor (Mongolia)

immunitor.mnROR OpenAlex
Research works
2
▲ 15% vs 2018-21
Citations
15
8.4 per fractional work
Top-10% rate
19.6%
all institutions 10.0%
Open access
76%
world 40%
International
63%
world 18%
Immunitor (Mongolia)

Not ranked overall: Immunitor (Mongolia) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Immunitor (Mongolia) work in?

In all years, 71% of research at Immunitor (Mongolia) is in Health Sciences, 18% in Physical Sciences. Its largest fields are Medicine (71%), Environmental Science (12%), Agricultural and Biological Sciences (6%).

Health Sciences: 1 fractional works · 70.6% of its workMedicine: 1 fractional works · 70.6% of its workPhysical Sciences: 0 fractional works · 17.6% of its workEnvironmental Science: 0 fractional works · 11.8% of its workEarth and Planetary Sciences: 0 fractional works · 5.9% of its workLife Sciences: 0 fractional works · 11.8% of its workAgricultural and Biological Sciences: 0 fractional works · 5.9% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 5.9% of its workALL ITS WORKImmunitor(Mongolia)2fractional works, all years
Life Sciences12%Physical Sciences18%Health Sciences71%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 5 fields, with their numbers
    1. Medicine170.6%
    1. Environmental Science011.8%
    2. Earth and Planetary Sciences05.9%
    1. Agricultural and Biological Sciences05.9%
    2. Biochemistry, Genetics and Molecular Biology05.9%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Immunitor (Mongolia)?

The most cited paper from Immunitor (Mongolia) is "Phase III, placebo-controlled, randomized, double-blind trial of tableted, therapeutic TB vaccine (V7) containing heat-killed M. vaccae administered daily for one month" (Aldar S. Bourinbaiar et al., 2019), with 32 citations. Next come "Randomized, placebo-controlled phase II trial of heat-killedMycobacterium vaccae(Longcom batch) formulated as an oral pill (V7)" (28) and "Effect of pneumococcal conjugate vaccination on pneumococcal carriage in hospitalised children aged 2–59 months in Mongolia: an active pneumonia surveillance programme" (16).

Most cited papers
#PaperReleasedCitations
1 Phase III, placebo-controlled, randomized, double-blind trial of tableted, therapeutic TB vaccine (V7) containing heat-killed M. vaccae administered daily for one month Aldar S. Bourinbaiar et al. · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases Open access 12 Dec 2019 32
2 Randomized, placebo-controlled phase II trial of heat-killedMycobacterium vaccae(Longcom batch) formulated as an oral pill (V7) Yuri V Efremenko, Dmytro Butov, Natalia D Prihoda et al. · Human Vaccines & Immunotherapeutics Open access 29 Jul 2013 28
3 Effect of pneumococcal conjugate vaccination on pneumococcal carriage in hospitalised children aged 2–59 months in Mongolia: an active pneumonia surveillance programme Claire von Mollendorf, Tuya Mungun, Munkhchuluun Ulziibayar et al. · The Lancet Microbe Open access 30 Oct 2024 16
4 Double-Blind, Placebo-Controlled, 1:1 Randomized Phase III Clinical Trial Of Immunoxel Honey Lozenges as an Adjunct Immunotherapy in 269 Patients with Pulmonary Tuberculosis Uyanga Batbold et al. · Immunotherapy 21 Nov 2016 14
5 Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L Marina G Tarakanovskaya, Jigjidsuren Chinburen, Purev Batchuluun et al. · Journal of Hepatocellular Carcinoma Open access Apr 2017 9
All 8 most cited papers, with filters and sorting

Which research topics does Immunitor (Mongolia) publish most on?

By volume in 2022-now: Reproductive Biology and Fertility, Assisted Reproductive Technology and Twin Pregnancy, Ovarian function and disorders and Respiratory viral infections research.

Reproductive Biology and…0Reproductive Biology and Fertility: 0 fractional worksAssisted Reproductive Te…0Assisted Reproductive Technology and Twin Pregnancy: 0 fractional worksOvarian function and dis…0Ovarian function and disorders: 0 fractional works
Public Health, Environmental and Occupational HealthPediatrics, Perinatology and Child HealthReproductive Medicine

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Reproductive Biology and Fertility Public Health, Environmental and Occupational Health 0 works
  2. 2 Assisted Reproductive Technology and Twin Pregnancy Pediatrics, Perinatology and Child Health 0 works
  3. 3 Ovarian function and disorders Reproductive Medicine 0 works
  4. 4 Respiratory viral infections research Epidemiology 0 works
  5. 5 Influenza Virus Research Studies Epidemiology 0 works
  6. 6 Pneumonia and Respiratory Infections Epidemiology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available76.3%not open23.7%

World: 40% of research is openly available.

with international co-authors62.8%domestic only37.2%

World: 18% is written across borders.

How has Immunitor (Mongolia)'s research output changed?

Output in 2022-2025 was 15% higher than in 2018-2021.

20152020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Ulaanbaatar

All research institutions in Ulaanbaatar

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Immunitor (Mongolia). Posts are plain text and can be reported.